3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
26
Carcinoma, Non-Small-Cell Lung
18
Urinary Bladder Neoplasms
16
Lung Neoplasms
13
Ovarian Neoplasms
9
Nasopharyngeal Carcinoma
9
Neoplasm Metastasis
8
Non-Muscle Invasive Bladder Neoplasms
7
Cholangiocarcinoma
7
Biliary Tract Neoplasms
7
Breast Neoplasms
6
Triple Negative Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Colorectal Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Carcinoma, Transitional Cell
4
Recurrence
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Urologic Neoplasms
2
Rectal Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Colonic Neoplasms
2
Bile Duct Neoplasms
2
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Gemcitabine
×
30 days
×
Clear all
No trials found.